Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00934375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00934375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
Lead sponsor
Eisai Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
September 30, 2007
Enrollment
145 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment